Neurocrine Biosciences
NBIX
#1462
Rank
S$16.07 B
Marketcap
$161.23
Share price
3.94%
Change (1 day)
-8.17%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): S$0.68 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are S$2.35 Billion. , an increase over its 2023 earnings that were of S$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 S$0.68 B64.57%
2023 S$0.41 B41.13%
2022 S$0.29 B73.74%
2021 S$0.16 B-8.82%
2020 S$0.18 B77.78%
2019 S$0.10 B49.83%
2018 S$69.96 M-142.57%
2017 -S$0.17 Billion-14.73%
2016 -S$0.2 Billion53.15%
2015 -S$0.13 Billion46.25%
2014 -S$86.05 Million29.66%
2013 -S$66.37 Million-3530.8%
2012 S$1.93 M-95.73%
2011 S$45.31 M
2009 -S$63.71 Million-45.38%
2008 -S$0.12 Billion-58.87%
2007 -S$0.29 Billion87.3%
2006 -S$0.16 Billion351.97%
2005 -S$33.5 Million-52.09%
2004 -S$69.92 Million-10.98%
2003 -S$78.54 Million
2001 -S$58.63 Million
1999 -S$26.44 Million108.32%
1998 -S$12.7 Million
1996 S$3.87 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$25.68 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.07 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-S$43.21 Million-106.30%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.56 B 1,877.50%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.61 B 1,302.10%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.27 B 1,252.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$10.03 Million-101.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$55.79 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA